Sarpogrelate

Sarpogrelate

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	none
Identifiers
IUPAC name 4-[2-(dimethylamino)-1-({2-[2-(3-methoxyphenyl)ethyl]phenoxy}methyl)ethoxy]-4-oxobutanoic acid
Synonyms	Sarpogrelate, (−)-4-[1-dimethylamino-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid
CAS Number	125926-17-2 Y
PubChem CID	5160
IUPHAR/BPS	210
ChemSpider	4976 N
UNII	19P708E787
ChEMBL	CHEMBL52939 N
Chemical and physical data
Formula	C24H31NO6
Molar mass	429.506 g/mol
3D model (Jmol)	Interactive image
SMILES CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
InChI InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27) N Key:FFYNAVGJSYHHFO-UHFFFAOYSA-N N
NY (what is this?)

Sarpogrelate (brand name Anplag; former developmental code names MCI-9042, LS-187,118) is a drug which acts as an antagonist at the 5HT_2A and 5-HT_2Breceptors. It blocks serotonin-induced platelet aggregation, and has applications in the treatment of many diseases including diabetes mellitus,Buerger's disease,Raynaud's disease,coronary artery disease,angina pectoris, and atherosclerosis.